Navigation Links
Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
Date:10/5/2007

DETROIT, Oct. 5 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd., (Amex: CPD) announced today that the US Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Cetirizine Hydrochloride Chewable Tablets, 5 mg and 10 mg (Cetirizine HCl Chewable). Final approval to market this product is anticipated subsequent to the expiry of patent protection on December 25, 2007.

Cetirizine HCl Chewable is indicated for the relief of symptoms associated with seasonal allergic rhinitis due to allergens in adults and children 2 years of age and older; perennial allergic rhinitis in adults and children 6 months of age and older; and for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older. This tentative approval is the bioequivalent to Zyrtec Chewable(R), a registered trademark of Pfizer, Inc. Zyrtec Chewable(R) tablets had U.S. sales of approximately $75 million for the 12-month period ended June 30, 2007, according to IMS Data.

Daniel H. Movens, Caraco's Chief Executive Officer, said, "We are extremely pleased to receive this tentative approval and look forward to the expiration date of the patent on December 25, 2007, which will allow Caraco to market the product. We feel that Cetirizine HCl Chewable complements our previously announced FDA tentative approval of Cetirizine Hydrochloride Immediate Release Tablets, 5 mg and 10 mg, and both products will be positive additions to our portfolio by expanding our product offerings."

Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops, manufactures, markets and distributes generic and priva
'/>"/>

SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. South Africa Wins landmark case against pharmaceutical giants
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Setting up a new pharmaceutical industry in India
5. Medicis Pharmaceutical company enters pediatric market
6. Supply of Radiopharmaceuticals Hampered by Attacks
7. Pharmaceutical companies are targeting patients
8. FDA approves Watson Pharmaceuticals Oxytrol patch
9. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
10. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
11. Pharmaceutical industries grant for R&D to be monitored
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... 30, 2015 , ... WellSpan Health in York, Pa., has ... claims for bariatric surgery that, despite complying with national and local coverage determinations, ... nurse auditor at WellSpan Health, tells Atlantic Information Services’ (AIS) Report on Medicare ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... ... the largest amount of research grants in its history of funding brain aneurysm ... professionals who have dedicated their life’s work toward scientific research directed at early ...
(Date:7/30/2015)... ... July 30, 2015 , ... Case Mason ( http://www.casemason.com ... consumer brands, recently completed a consolidation of all of its production capabilities to ... out of two separate locations situated 11 miles apart. , The advantages of ...
(Date:7/30/2015)... ... July 30, 2015 , ... World Breast-Feeding Week (Aug. 1-7) ... children have the nutrition required to grow into healthy adults. Medicationdiscountcard.com ... many prescription pre-natal vitamins. , Folic Acid , Arguably one of the most ...
(Date:7/29/2015)... Francisco, California (PRWEB) , ... July 30, 2015 , ... ... Jimi Hendrix Dorton Arena Raleigh North Carolina concert posters. The same poster art was ... were printed by Globe Poster based in Baltimore and are classic boxing style concert ...
Breaking Medicine News(10 mins):Health News:Hospital Details Fight for Bariatric Surgery Reimbursement in AIS Newsletter 2Health News:Hospital Details Fight for Bariatric Surgery Reimbursement in AIS Newsletter 3Health News:Brain Aneurysm Foundation to Award Largest Amount of Research Funding 2Health News:Brain Aneurysm Foundation to Award Largest Amount of Research Funding 3Health News:Brain Aneurysm Foundation to Award Largest Amount of Research Funding 4Health News:Case Mason Consolidates Operations to Larger Facility for Increased Efficiency, Improved Service 2Health News:Case Mason Consolidates Operations to Larger Facility for Increased Efficiency, Improved Service 3Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 2Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 3Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 4
... rose during the Great Depression, study shows , ... may not be all bad. In fact, U.S. researchers ... University of Michigan researchers looked at death rates during ... 20th century. From the stock market crash of 1929 ...
... women with metastatic colorectal cancer lived longer than younger ... a benefit from estrogen or other hormones, according to ... Research , a journal of the American Association for ... that estrogen prevents colorectal cancer, but this is the ...
... of Texas Health Science Center at Houston and the ... launch a study of Jamaican children that they hope ... may interact to cause autism spectrum disorders. The ... the National Institute of Child Health and Human Development ...
... study finds, , TUESDAY, Sept. 29 (HealthDay News) -- Despite ... know about national recommendations for a minimum of 30 minutes ... goal, a new study has found. , The lack of ... in the United States, the researchers said. Their finding came ...
... Black Women,s Health Study (BWHS) of the Sloan Epidemiology ... received a five-year continuation of grant funding award from ... years 16-20 of the largest follow-up study of the ... associate director of the Slone Epidemiology Center and professor ...
... RIVERSIDE, Calif. A deadly disease, malaria afflicts 350-500 ... a million people. Transmitted by Anopheles mosquitoes, the ... with at least 40 percent of the world,s population ... is the development of an effective malaria vaccine. Yet, ...
Cached Medicine News:Health News:Could the Recession Be Good for Your Health? 2Health News:Could the Recession Be Good for Your Health? 3Health News:Could the Recession Be Good for Your Health? 4Health News:Women fare better than men with metastatic colorectal cancer -- are hormones helping? 2Health News:UT Houston, Jamaica researchers launch autism study 2Health News:UT Houston, Jamaica researchers launch autism study 3Health News:Exercise 30 Minutes a Day? Who Knew! 2Health News:Book by UCR biologist tells story of 100-year quest for elusive malaria vaccine 2Health News:Book by UCR biologist tells story of 100-year quest for elusive malaria vaccine 3Health News:Book by UCR biologist tells story of 100-year quest for elusive malaria vaccine 4
(Date:7/30/2015)... 30, 2015 What can be ... areas are going to grow at the fastest rates? ... revenues to 2025, assessing data, trends, opportunities and prospects ... 176 tables, charts, and graphs. Discover the most lucrative ... Our new study lets you assess forecasted sales at ...
(Date:7/30/2015)...  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) today ... at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) ... 2015 financial results and provide a corporate update. Arena ... Select Market closes that day. The conference ... callers and 914.495.8552 for international callers. Please specify to ...
(Date:7/30/2015)... HeartWare International, Inc . (NASDAQ: HTWR ), ... support technologies that are revolutionizing the treatment of ... $73.6 million for the quarter ended June 30, ... ended June 30, 2014.  Currency fluctuations impacted revenue ... points, during the three months ended June 30, ...
Breaking Medicine Technology:Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 6Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 2Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 3Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 4HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 2HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 3HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 4HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 5HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 6HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 7HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 8HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 9HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 10HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 11HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 12HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 13HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 14
... Ore.--(BUSINESS WIRE)--May 1, 2007 - AVI BioPharma, ... of NEUGENE(R) antisense compounds,against seasonal influenza A ... professor, Department of Microbiology and Immunology,Tulane University ... poster,form at the 20th International Conference on ...
... -- CEL-SCI,CORPORATION announces that CEL-1000 alone increased ... that the combination of,CEL-1000 with MAS-1, a ... Pharma, induced highly significant increases,in specific anti-HBV ... by Dr. Daniel Zimmerman, Senior Vice President ...
Cached Medicine Technology:AVI BioPharma Reports Positive Pre-Clinical Influenza Data 2AVI BioPharma Reports Positive Pre-Clinical Influenza Data 3CEL-SCI's Cel-1000 Shown to Significantly Enhance Immune Response,Against Hepatitis B Antigen in Animals 2
... H 2 O W/O Adapter., ... these humidifier systems feature a dual-purpose reservoir with ... for secure attachment of a humidifier adapter. The ... from reaching oxygen delivery tubing. An audible relief ...
Respirgard II Nebulizer System with Acorn II Nebulizer, 7' (2 m) supply tubing, universal "antidrool" tee, mouthpiece, 6" (15 cm) aerosol tube, wye, one-way valve and expiratory filter...
MISTY OX® Hi-Fi Nebulizer...
... The Raindrop® medication nebulizer achieves optimum ... MMAD particle size range is 1.04-1.10 µ ... compressor or air outlet., ,As the ... gives healthcare providers the assurance of proven ...
Medicine Products: